-17.2%
DASH vs MRNA
+945.0%
-962.2%
-38.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +8.3% | +13.1% | -4.8% | +7.9% |
| 7D | +17.2% | +20.6% | -3.5% | +16.5% |
| 30D | +3.6% | +27.1% | -23.6% | +2.7% |
| 3M | -1.9% | +353.4% | -355.2% | -9.2% |
| 6M | +15.1% | +446.3% | -431.2% | +2.7% |
| YTD | -12.3% | +776.2% | -788.5% | -25.3% |
| 1Y | -17.2% | +987.9% | -1,005.1% | -30.1% |
| All | -17.2% | +945.0% | -962.2% | -30.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling